Baker Tilly Wealth Management, LLC Regeneron Pharmaceuticals, Inc. Transaction History
Baker Tilly Wealth Management, LLC
- $220 Million
- Q3 2024
A detailed history of Baker Tilly Wealth Management, LLC transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Baker Tilly Wealth Management, LLC holds 736 shares of REGN stock, worth $544,647. This represents 0.35% of its overall portfolio holdings.
Number of Shares
736
Previous 599
22.87%
Holding current value
$544,647
Previous $629,000
22.89%
% of portfolio
0.35%
Previous 0.26%
Shares
16 transactions
Others Institutions Holding REGN
# of Institutions
1,535Shares Held
83.8MCall Options Held
1.22MPut Options Held
1.51M-
Vanguard Group Inc Valley Forge, PA9.32MShares$6.9 Billion0.18% of portfolio
-
Black Rock Inc. New York, NY8.45MShares$6.25 Billion0.2% of portfolio
-
Jpmorgan Chase & CO New York, NY7.49MShares$5.54 Billion0.65% of portfolio
-
State Street Corp Boston, MA4.9MShares$3.63 Billion0.21% of portfolio
-
Capital World Investors Los Angeles, CA4.3MShares$3.18 Billion0.72% of portfolio
About REGENERON PHARMACEUTICALS, INC.
- Ticker REGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 107,190,000
- Market Cap $79.3B
- Description
- Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...